A causal association between Epstein-Barr virus infection and lung cancer: A two-sample Mendelian Randomization study
Cancer Biomarkers · 2026-06 · 43
DOI: 10.1177/18758592261463308 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cancer Biomarkers, online erschienen am 04.07.2026. Verfasst von Jia Wang und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Oncology, Affiliated Hospital of Yan 'an University, Yan 'an, Shaanxi, China. Hauptthemen laut MEDLINE: Lung Neoplasms, Epstein-Barr Virus Infections, Herpesvirus 4, Human. Die Arbeit nennt 35 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Background
The association between Epstein-Barr virus (EBV) and lung cancer risk remains controversial. Here, we used a two-sample Mendelian randomization (MR) analysis to test the causal relationship between EBV and lung cancer.
Methods
Data regarding lung cancer (outcomes) were collected from the Finnish database; the Genome-Wide Association Study (GWAS) summary-level dataset for EBV was obtained from the Open Forum Infect Dis. The inverse-variance weighted (IVW) method was used as a primary analytical approach; weighted median, MR-Egger, and weighted mode methods were used to ensure the robustness of the data. The MR-Egger regression assessed horizontal pleiotropy, and the MR pleiotropy residual sum and outlier (MR-PRESSO) method identified potential outliers. Cochran’s Q test evaluated heterogeneity among instrumental variables (IVs).
Results
IVW analysis indicated several significant causal effects. Genetically elevated levels of EBV ZEBRA and EBNA-1 antibodies increased the risk of SQC (OR=1.26 and OR=1.33, respectively). Increased EBNA-1 antibodies also raised the risk of overall lung cancer and small cell lung cancer. Conversely, higher VCA p18 antibody levels were associated with a decreased risk of lung adenocarcinoma (OR=0.70). Sensitivity analyses suggested these findings were robust, with no significant evidence of horizontal pleiotropy or heterogeneity.
Conclusion
Our data suggests a causal effect between EBV and the progression of lung cancer.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Oncology, Affiliated Hospital of Yan 'an University, Yan 'an, Shaanxi, China.
- Department of Thoracic Surgery, Affiliated Hospital of Yan 'an University, Yan 'an, Shaanxi, China.
ORCID-Profile: Kai Wang
Zitieren
APA
Wang, J., Wang, K., & Wang, Z. (2026). A causal association between Epstein-Barr virus infection and lung cancer: A two-sample Mendelian Randomization study. Cancer Biomarkers, 43. https://doi.org/10.1177/18758592261463308
Vancouver
Wang J, Wang K, Wang Z. A causal association between Epstein-Barr virus infection and lung cancer: A two-sample Mendelian Randomization study. Cancer Biomarkers. 2026;43. doi:10.1177/18758592261463308
BibTeX
@article{Wang2026,
author = {Wang, Jia and Wang, Kai and Wang, Zhishang},
title = {A causal association between Epstein-Barr virus infection and lung cancer: A two-sample Mendelian Randomization study},
journal = {Cancer Biomarkers},
year = {2026},
volume = {43},
doi = {10.1177/18758592261463308}
}
EUVIMED